MA
Mangalam Drugs & Organics Limited
MANGALAM.BO · BSE
₹29.41 +0.79% (+₹0.23)
1M +8.03%
Market Cap ₹461.9M
P/E Ratio -
Div. Yield -
ROE 30.16%
Bulios Fair Price
₹40.79
38.7% upside
Current Price
₹29.41
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MANGALAM.BO is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
76 /100
Cheap P/FCF 24.13x
P/S 0.20x
P/B 0.45x
Growth
3 /100
Declining Book val. growth 0.35%
EPS growth 30.06%
Rev. growth 10.79%
Profitability
6 /100
Weak Op. margin 11.55%
Gross margin 12.33%
FCF margin 0.82%
Quality
9 /100
Poor ROA 12.14%
ROIC 11.26%
Asset turnover 0.74x
Debt
28 /100
High Int. coverage -1.68x
Debt/Equity 1.02x
Current ratio 0.79x
Stability
32 /100
Unstable EPS volatility 512.33%
Beta 0.17x
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MANGALAM.BO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Govardhan Murlidhar Dhoot
Employees
432
Headquarters
Mumbai